Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;61(10):2958-2968.
doi: 10.1111/trf.16595. Epub 2021 Jul 17.

Risk of transfusion-transmitted Babesia microti in Canada

Sheila F O'Brien  1   2 , Steven J Drews  3   4 , Qi-Long Yi  1 , Evan M Bloch  5 , Nicholas H Ogden  6 , Jules K Koffi  6 , Leslie Robbin Lindsay  7 , Yves Gregoire  8 , Gilles Delage  9
Affiliations

Risk of transfusion-transmitted Babesia microti in Canada

Sheila F O'Brien et al. Transfusion. 2021 Oct.

Abstract

Background: Babesia microti has gained a foothold in Canada as tick vectors become established in broader geographic areas. B. microti infection is associated with mild or no symptoms in healthy individuals but is transfusion-transmissible and can be fatal in immunocompromised individuals. This is the first estimate of clinically significant transfusion-transmitted babesiosis (TTB) risk in Canada.

Study design and methods: The proportion of B. microti-antibody (AB)/nucleic acid amplification test (NAT)-positive whole blood donations was estimated at 5.5% of the proportion of the general population with reported Lyme Disease (also tick-borne) based on US data. Monte Carlo simulation estimated the number and proportion of infectious red cell units for three scenarios: base, localized incidence (risk in Manitoba only), and donor study informed (prevalence from donor data). The model simulated 1,029,800 donations repeated 100,000 times for each.

Results: In the base scenario 0.5 (0.01, 1.75), B. microti-NAT-positive donations would be expected per year, with 0.08 (0, 0.38) recipients suffering clinically significant TTB (1 every 12.5 years). In the localized incidence scenario, there were 0.21(0, 0.7) B. microti-NAT-positive donations, with 0.04 (0, 0.14) recipient infections (about 1 every 25 years). In the donor study informed scenario, there were 4.6 (0.3, 15.8) B. microti-NAT-positive donations expected, and 0.81 (0.05, 3.14) clinically significant TTB cases per year.

Discussion: The likelihood of clinically relevant TTB is low. Testing would have very little utility in Canada at this time. Ongoing pathogen surveillance in tick vectors is important as B. microti prevalence appears to be slowly increasing in Canada.

Keywords: Babesia microti; Canada; risk model; transfusion.

PubMed Disclaimer

References

REFERENCES

    1. Vannier EG, Diuk-Wasser MA, Mamoun CB, Krause PJ. Babesiosis. Infet Dis Clin North Am. 2015;29:357-70.
    1. Vannier E, Krause PJ. Human babesiosis. New Engl J Med. 2012;366:2397-407.
    1. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509-19.
    1. Tonnetti L, Townsend RL, Dodd RY, Stramer SL. Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017. Transfusion. 2019;59:2908-12.
    1. Krause PJ. Human babesiosis. Int J Parasitol. 2019;49:165-74.

Publication types

LinkOut - more resources